PERSONALIZED T-CELL IMMUNOTHERAPY FOR RENAL CELL CARCINOMA

$688,237FY2019Defense Health AgencyDOD

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators

View source on USAspending →